VAR2 Pharmaceuticals

... is a privately held biotechnology company engaged in the design and development of proprietary therapeutic proteins targeting cancer-specific carbohydrate structures for multiple cancer indications.

About VAR2 Pharmaceuticals

VAR2 Pharmaceuticals is a privately held biotechnology company engaged in the design and development of proprietary therapeutic proteins targeting cancer-specific carbohydrate structures for multiple cancer indications. We have a portfolio of proteins with unique affinity and specificity for these cancer-associated carbohydrates for the development of treatments for cancers where there is no effective therapy, such as sarcoma, triple negative breast cancers and prostate cancer.

The technology is based on groundbreaking discoveries made by researchers at University of Copenhagen, Denmark, in collaboration with partners at University of British Columbia, Canada.

Read more
13 April 2018
Uncategorized
VAR2 Pharmaceuticals founder and member of the Board of Directors, Prof. Poul Sorensen, will give a talk with the title “Probing the surface proteome for immunotherapy targets in high-risk pediatric cancers” on Saturady April 14th at the AACR meeting in Chicago, IL. The presentation will highlight s...
07 April 2018
Uncategorized
New significant data about chondroitin sulphate – the target for the VAR2 protein – in prostate cancer, will be presented on April 18th, at this year's AACR meeting in Chicago, IL. The work is presented in a poster entitled “Expression and regulation of chondroitin sulfate in prostate cancer” and is...
24 November 2017
Uncategorized
Today the Innovation Fund Denmark (innovationsFonden) granted 1 million DKK over 3 years to VAR2 Pharmaceuticals and Copenhagen University to fund an Industry PhD student in the project “Cancer immunotherapy based on a malaria protein”. We are very happy for the grant and look forward to work with t...
02 November 2017
Uncategorized

VAR2 Pharmaceuticals will take part in the 23rd annual BIO-Europe partnering conference, 6-8 November 2017, in Berlin. With a full meeting schedule we look forward to have many fruitful discussions with potential partners in the pharma and biotech industry. See you there!

Our Investors

VAR2 Pharmaceuticals is owned by the inventor group and University of Copenhagen, and we are financed by private investors.

Read More

Want to be a partner?

To discuss a potential partnership opportunity with VAR2 Pharmaceuticals please contact us

Read more